Results 201 to 210 of about 1,822 (274)

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen. [PDF]

open access: yesEur J Neurol
Coratti G   +34 more
europepmc   +1 more source

UEG Week 2025 Oral Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S7-S188, October 2025.
wiley   +1 more source

Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy. [PDF]

open access: yesJ Neurol
Dobelmann V   +10 more
europepmc   +1 more source

UEG Week 2025 Moderated Posters

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley   +1 more source

Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies. [PDF]

open access: yesBMJ Paediatr Open
Sakpichaisakul K   +6 more
europepmc   +1 more source

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Pediatric non-Hodgkin lymphoma as a rare cause of spinal cord injury: When lymphoma hides in the canal. [PDF]

open access: yesClin Case Rep
Zama D   +7 more
europepmc   +1 more source

Telemedicine for Personalized Nutritional Intervention of Rare Diseases: A Narrative Review on Approaches, Impact, and Future Perspectives. [PDF]

open access: yesNutrients
Eletti F   +9 more
europepmc   +1 more source

Spinal muscular atrophy in childhood

open access: closedSeminars in Pediatric Neurology, 1996
Diagnosis and classification of spinal muscular atrophy (SMA) in childhood are based on clinical, electrophysiological, and histological studies. The concept of maturational arrest of motoneurons and their targets (muscle cells in SMA type I) is documented by ultrastructural and immunohistochemical data.
Anna Fidziańska
openalex   +4 more sources

Home - About - Disclaimer - Privacy